Issue navigation
Volume 31, Issue 4, April 2025
Leading Off
HLA-DQA1*05 Allele Carriage and Anti-TNF Therapy Persistence in Inflammatory Bowel Disease
Inflammatory Bowel Diseases, Volume 31, Issue 4, April 2025, Pages 903–911, https://doi.org/10.1093/ibd/izae138
Expression Profile of MicroRNAs in Breast Milk of Women With Inflammatory Bowel Disease: Correlation With Disease Activity and Medical Treatments
Inflammatory Bowel Diseases, Volume 31, Issue 4, April 2025, Pages 912–922, https://doi.org/10.1093/ibd/izae290
Clinical Research
The Effect of Etrasimod on Fecal Calprotectin and High-sensitivity C-reactive Protein: Results From the ELEVATE UC Clinical Program
Inflammatory Bowel Diseases, Volume 31, Issue 4, April 2025, Pages 923–934, https://doi.org/10.1093/ibd/izae111
Increasing Rates of Bowel Resection Surgery for Stricturing Crohn’s Disease in the Biologic Era
Inflammatory Bowel Diseases, Volume 31, Issue 4, April 2025, Pages 935–943, https://doi.org/10.1093/ibd/izae113
Endoscopic Balloon Dilatation of Ileal Pouch-Anal Anastomosis Strictures in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis
Inflammatory Bowel Diseases, Volume 31, Issue 4, April 2025, Pages 944–951, https://doi.org/10.1093/ibd/izae128
Mortality of Patients With Inflammatory Bowel Disease in the Faroe Islands From 1966-2020
Inflammatory Bowel Diseases, Volume 31, Issue 4, April 2025, Pages 952–962, https://doi.org/10.1093/ibd/izae120
Identification of the M2 Macrophage-associated Gene THBS2 as a Predictive Marker for Inflammatory Cancer Transformation
Inflammatory Bowel Diseases, Volume 31, Issue 4, April 2025, Pages 963–974, https://doi.org/10.1093/ibd/izae129
Similar Efficacy of Mesalazine in Adult and Older Adult Ulcerative Colitis Patients: Post Hoc Analysis of a Randomized Noninferiority Trial of 1600 mg vs 400 mg Tablets
Inflammatory Bowel Diseases, Volume 31, Issue 4, April 2025, Pages 975–982, https://doi.org/10.1093/ibd/izae123
Integrating the Patient Perspective to Validate a Measure of Disease Severity in Inflammatory Bowel Disease: Online Survey of Patients and Their Physicians
Inflammatory Bowel Diseases, Volume 31, Issue 4, April 2025, Pages 983–994, https://doi.org/10.1093/ibd/izae127
Paternal Inflammatory Bowel Disease and the Risk of Pregnancy Loss
Inflammatory Bowel Diseases, Volume 31, Issue 4, April 2025, Pages 995–1002, https://doi.org/10.1093/ibd/izae132
Long-Term Outcomes of Intravenous Ustekinumab Maintenance Treatment in Patients With Loss of Response to Subcutaneous Dosing
Inflammatory Bowel Diseases, Volume 31, Issue 4, April 2025, Pages 1003–1009, https://doi.org/10.1093/ibd/izae152
Concomitant Administration of Ozanimod and Serotonergic Antidepressants in Patients With Ulcerative Colitis or Relapsing Multiple Sclerosis
Inflammatory Bowel Diseases, Volume 31, Issue 4, April 2025, Pages 1010–1017, https://doi.org/10.1093/ibd/izae136
High Healthcare Costs in Childhood Inflammatory Bowel Disease: Development of a Prediction Model Using Linked Clinical and Health Administrative Data
Inflammatory Bowel Diseases, Volume 31, Issue 4, April 2025, Pages 1018–1031, https://doi.org/10.1093/ibd/izae148
Invasive Therapeutic Strategies for Stricturing Crohn’s Disease in Childhood: A Systematic Review and Meta-Analysis
Inflammatory Bowel Diseases, Volume 31, Issue 4, April 2025, Pages 1032–1040, https://doi.org/10.1093/ibd/izae144
IBD Is Like a Tree: Reflections From Older Adults With Inflammatory Bowel Disease
Inflammatory Bowel Diseases, Volume 31, Issue 4, April 2025, Pages 1041–1050, https://doi.org/10.1093/ibd/izae139
Basic Science Research
Stromal Cell Subsets Show Model-Dependent Changes in Experimental Colitis and Affect Epithelial Tissue Repair and Immune Cell Activation
Inflammatory Bowel Diseases, Volume 31, Issue 4, April 2025, Pages 1051–1066, https://doi.org/10.1093/ibd/izae255
A Similar Mutation in the AAUU-Rich Elements of the Mouse TNF Gene Results in a Distinct Ileocolitic Phenotype: A New Strain of TNF-Overexpressing Mice
Inflammatory Bowel Diseases, Volume 31, Issue 4, April 2025, Pages 1067–1081, https://doi.org/10.1093/ibd/izae307
Inflammation-Induced Th17 Cells Synergize with the Inflammation-Trained Microbiota to Mediate Host Resiliency Against Intestinal Injury
Inflammatory Bowel Diseases, Volume 31, Issue 4, April 2025, Pages 1082–1094, https://doi.org/10.1093/ibd/izae293
Translational Research
Mediators of Filgotinib Treatment Effects in Ulcerative Colitis: Exploring Circulating Biomarkers in the Phase 2b/3 SELECTION Study
Inflammatory Bowel Diseases, Volume 31, Issue 4, April 2025, Pages 1095–1108, https://doi.org/10.1093/ibd/izae278
Escherichia coli Nissle Improves Short-Chain Fatty Acid Absorption and Barrier Function in a Mouse Model for Chronic Inflammatory Diarrhea
Inflammatory Bowel Diseases, Volume 31, Issue 4, April 2025, Pages 1109–1120, https://doi.org/10.1093/ibd/izae294
Clinical Reviews
Food-Based Interventions as Therapy for Inflammatory Bowel Disease: Important Steps in Diet Trial Design and Reporting of Outcomes
Inflammatory Bowel Diseases, Volume 31, Issue 4, April 2025, Pages 1121–1137, https://doi.org/10.1093/ibd/izae185
Combined Advanced Targeted Therapy in Inflammatory Bowel Diseases: An Extensive Update
Inflammatory Bowel Diseases, Volume 31, Issue 4, April 2025, Pages 1138–1144, https://doi.org/10.1093/ibd/izae189
Upadacitinib for Acute Severe Ulcerative Colitis: A Systematic Review
Inflammatory Bowel Diseases, Volume 31, Issue 4, April 2025, Pages 1145–1149, https://doi.org/10.1093/ibd/izae191
TOpClass Class 4 Perineal Crohn’s Disease: A Systematic Review and Meta-analysis of Perineal Wound Complication After Proctectomy in Crohn’s Patients
Inflammatory Bowel Diseases, Volume 31, Issue 4, April 2025, Pages 1150–1157, https://doi.org/10.1093/ibd/izae198
Basic Science Review
Winnie Mice: A Chronic and Progressive Model of Ulcerative Colitis
Inflammatory Bowel Diseases, Volume 31, Issue 4, April 2025, Pages 1158–1167, https://doi.org/10.1093/ibd/izaf006
Clinical Brief Report
Risk of Paradoxical Rheumatoid Arthritis in Inflammatory Bowel Disease Patients Exposed to Tumor Necrosis Factor Inhibitors: A Propensity-Matched Multicenter Study
Inflammatory Bowel Diseases, Volume 31, Issue 4, April 2025, Pages 1168–1173, https://doi.org/10.1093/ibd/izae203
Real-World Comparison of Effectiveness, Treatment Persistence, and Safety of First-Line Advanced Therapies at 1 Year for Ulcerative Proctitis
Inflammatory Bowel Diseases, Volume 31, Issue 4, April 2025, Pages 1174–1177, https://doi.org/10.1093/ibd/izae215
The Effectiveness of Risankizumab as Induction Therapy for Crohn’s Disease: Data From the Sicilian Network for Inflammatory Bowel Diseases
Inflammatory Bowel Diseases, Volume 31, Issue 4, April 2025, Pages 1178–1181, https://doi.org/10.1093/ibd/izae248
Case Report
Symptomatic and Sonographic Improvement of Immune Checkpoint Inhibitor Enterocolitis With Risankizumab
Inflammatory Bowel Diseases, Volume 31, Issue 4, April 2025, Pages 1182–1183, https://doi.org/10.1093/ibd/izae259
Invited Commentary
Altered Bile Acids and Pouch Microbiota Composition in Patients With Chronic Pouchitis
Inflammatory Bowel Diseases, Volume 31, Issue 4, April 2025, Pages 1184–1187, https://doi.org/10.1093/ibd/izaf005
Invited Editorial
Postpartum Wound Healing for Mothers with Inflammatory Bowel Disease: Cause for Worry? Insights from the Pregnancy in Inflammatory Bowel Disease and Neonatal Outcomes Registry
Inflammatory Bowel Diseases, Volume 31, Issue 4, April 2025, Pages 1188–1189, https://doi.org/10.1093/ibd/izae309
Letters to the Editor
Is Sarcopenia More Than Just Low Body Mass?
Inflammatory Bowel Diseases, Volume 31, Issue 4, April 2025, Page 1190, https://doi.org/10.1093/ibd/izae286
Author’s Reply: Is Sarcopenia More Than Just Low Body Mass?
Inflammatory Bowel Diseases, Volume 31, Issue 4, April 2025, Pages 1191–1192, https://doi.org/10.1093/ibd/izae285
Opioids Intertwined With Psychology: Hidden Effects in the Treatment of Patients With IBD
Inflammatory Bowel Diseases, Volume 31, Issue 4, April 2025, Pages 1193–1194, https://doi.org/10.1093/ibd/izae300
Reply: Opioids Intertwined With Psychology: Hidden Effects in the Treatment of Patients With IBD
Inflammatory Bowel Diseases, Volume 31, Issue 4, April 2025, Pages 1195–1196, https://doi.org/10.1093/ibd/izae305
